ISIS in C/W's "Not Better Late Than Never" By Michael Shulman http://www.changewave.com/freecontent/2007/09/freemidms20070921.html excerpt: Isis Pharmaceuticals (ISIS) ...This company was in the news recently for cutting a major deal to work collaboratively with Alnylam to form a company called Regulus Therapeutics to do research in microRNA, a derivative technology. Why? To eventually take this new outfit public because they are tired of losing money on RNAi research without a payoff...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.